1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global oral solid dosage (OSD) contract manufacturing market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global oral solid dosage (osd) contract manufacturing market 2017 – 2021 ($ billion)
o 4.2 End-user Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – End-user Segment 2017 – 2021 ($ billion)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user – Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Large-size companies – Market size and forecast 2022-2027
o Exhibit 34: Chart on Large-size companies – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Large-size companies – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Large-size companies – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Large-size companies – Year-over-year growth 2022-2027 (%)
o 6.4 Small and medium size companies – Market size and forecast 2022-2027
o Exhibit 38: Chart on Small and medium size companies – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Small and medium size companies – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Small and medium size companies – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Small and medium size companies – Year-over-year growth 2022-2027 (%)
o 6.5 Startups and generic pharmaceutical companies – Market size and forecast 2022-2027
o Exhibit 42: Chart on Startups and generic pharmaceutical companies – Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Startups and generic pharmaceutical companies – Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Startups and generic pharmaceutical companies – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Startups and generic pharmaceutical companies – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ billion)
o Exhibit 47: Data Table on Market opportunity by End-user ($ billion)
7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product – Market share 2022-2027 (%)
o Exhibit 49: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 Tablets – Market size and forecast 2022-2027
o Exhibit 52: Chart on Tablets – Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Data Table on Tablets – Market size and forecast 2022-2027 ($ billion)
o Exhibit 54: Chart on Tablets – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Tablets – Year-over-year growth 2022-2027 (%)
o 7.4 Capsules – Market size and forecast 2022-2027
o Exhibit 56: Chart on Capsules – Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Data Table on Capsules – Market size and forecast 2022-2027 ($ billion)
o Exhibit 58: Chart on Capsules – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Capsules – Year-over-year growth 2022-2027 (%)
o 7.5 Powders – Market size and forecast 2022-2027
o Exhibit 60: Chart on Powders – Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Powders – Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Powders – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Powders – Year-over-year growth 2022-2027 (%)
o 7.6 Granules and others – Market size and forecast 2022-2027
o Exhibit 64: Chart on Granules and others – Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Granules and others – Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Granules and others – Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Granules and others – Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Product
o Exhibit 68: Market opportunity by Product ($ billion)
o Exhibit 69: Data Table on Market opportunity by Product ($ billion)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 Asia – Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 76: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.4 North America – Market size and forecast 2022-2027
o Exhibit 79: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.5 Europe – Market size and forecast 2022-2027
o Exhibit 83: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 China – Market size and forecast 2022-2027
o Exhibit 91: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.8 US – Market size and forecast 2022-2027
o Exhibit 95: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.9 Japan – Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.10 Canada – Market size and forecast 2022-2027
o Exhibit 103: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.11 Germany – Market size and forecast 2022-2027
o Exhibit 107: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 119: AbbVie Inc. – Overview
o Exhibit 120: AbbVie Inc. – Product / Service
o Exhibit 121: AbbVie Inc. – Key news
o Exhibit 122: AbbVie Inc. – Key offerings
o 12.4 Aenova Holding GmbH
o Exhibit 123: Aenova Holding GmbH – Overview
o Exhibit 124: Aenova Holding GmbH – Product / Service
o Exhibit 125: Aenova Holding GmbH – Key offerings
o 12.5 Boehringer Ingelheim International GmbH
o Exhibit 126: Boehringer Ingelheim International GmbH – Overview
o Exhibit 127: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 128: Boehringer Ingelheim International GmbH – Key news
o Exhibit 129: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 130: Boehringer Ingelheim International GmbH – Segment focus
o 12.6 Catalent Inc.
o Exhibit 131: Catalent Inc. – Overview
o Exhibit 132: Catalent Inc. – Business segments
o Exhibit 133: Catalent Inc. – Key news
o Exhibit 134: Catalent Inc. – Key offerings
o Exhibit 135: Catalent Inc. – Segment focus
o 12.7 Corden Pharma International GmbH
o Exhibit 136: Corden Pharma International GmbH – Overview
o Exhibit 137: Corden Pharma International GmbH – Product / Service
o Exhibit 138: Corden Pharma International GmbH – Key offerings
o 12.8 Jubilant Pharmova Ltd.
o Exhibit 139: Jubilant Pharmova Ltd. – Overview
o Exhibit 140: Jubilant Pharmova Ltd. – Business segments
o Exhibit 141: Jubilant Pharmova Ltd. – Key news
o Exhibit 142: Jubilant Pharmova Ltd. – Key offerings
o Exhibit 143: Jubilant Pharmova Ltd. – Segment focus
o 12.9 Lonza Group Ltd.
o Exhibit 144: Lonza Group Ltd. – Overview
o Exhibit 145: Lonza Group Ltd. – Business segments
o Exhibit 146: Lonza Group Ltd. – Key news
o Exhibit 147: Lonza Group Ltd. – Key offerings
o Exhibit 148: Lonza Group Ltd. – Segment focus
o 12.10 Merck KGaA
o Exhibit 149: Merck KGaA – Overview
o Exhibit 150: Merck KGaA – Business segments
o Exhibit 151: Merck KGaA – Key news
o Exhibit 152: Merck KGaA – Key offerings
o Exhibit 153: Merck KGaA – Segment focus
o 12.11 NextPharma GmbH
o Exhibit 154: NextPharma GmbH – Overview
o Exhibit 155: NextPharma GmbH – Product / Service
o Exhibit 156: NextPharma GmbH – Key offerings
o 12.12 PerkinElmer Inc.
o Exhibit 157: PerkinElmer Inc. – Overview
o Exhibit 158: PerkinElmer Inc. – Business segments
o Exhibit 159: PerkinElmer Inc. – Key news
o Exhibit 160: PerkinElmer Inc. – Key offerings
o Exhibit 161: PerkinElmer Inc. – Segment focus
o 12.13 Piramal Enterprises Ltd.
o Exhibit 162: Piramal Enterprises Ltd. – Overview
o Exhibit 163: Piramal Enterprises Ltd. – Business segments
o Exhibit 164: Piramal Enterprises Ltd. – Key offerings
o Exhibit 165: Piramal Enterprises Ltd. – Segment focus
o 12.14 Pyramid Laboratories Inc.
o Exhibit 166: Pyramid Laboratories Inc. – Overview
o Exhibit 167: Pyramid Laboratories Inc. – Product / Service
o Exhibit 168: Pyramid Laboratories Inc. – Key offerings
o 12.15 Recipharm AB
o Exhibit 169: Recipharm AB – Overview
o Exhibit 170: Recipharm AB – Business segments
o Exhibit 171: Recipharm AB – Key offerings
o Exhibit 172: Recipharm AB – Segment focus
o 12.16 Siegfried Holding AG
o Exhibit 173: Siegfried Holding AG – Overview
o Exhibit 174: Siegfried Holding AG – Business segments
o Exhibit 175: Siegfried Holding AG – Key offerings
o Exhibit 176: Siegfried Holding AG – Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 177: Thermo Fisher Scientific Inc. – Overview
o Exhibit 178: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 179: Thermo Fisher Scientific Inc. – Key news
o Exhibit 180: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 181: Thermo Fisher Scientific Inc. – Segment focus
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 182: Inclusions checklist
o Exhibit 183: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 184: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 185: Research methodology
o Exhibit 186: Validation techniques employed for market sizing
o Exhibit 187: Information sources
o 13.5 List of abbreviations
o Exhibit 188: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global oral solid dosage (osd) contract manufacturing market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – End-user Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – Product Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on End-user – Market share 2022-2027 (%)
Exhibits31: Data Table on End-user – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Large-size companies – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Large-size companies – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Large-size companies – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Large-size companies – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Small and medium size companies – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Small and medium size companies – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Small and medium size companies – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Small and medium size companies – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Startups and generic pharmaceutical companies – Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Startups and generic pharmaceutical companies – Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Startups and generic pharmaceutical companies – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Startups and generic pharmaceutical companies – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ billion)
Exhibits47: Data Table on Market opportunity by End-user ($ billion)
Exhibits48: Chart on Product – Market share 2022-2027 (%)
Exhibits49: Data Table on Product – Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on Tablets – Market size and forecast 2022-2027 ($ billion)
Exhibits53: Data Table on Tablets – Market size and forecast 2022-2027 ($ billion)
Exhibits54: Chart on Tablets – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Tablets – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Capsules – Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Capsules – Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Capsules – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Capsules – Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Powders – Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Powders – Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Powders – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Powders – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Granules and others – Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Granules and others – Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Granules and others – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Granules and others – Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Product ($ billion)
Exhibits69: Data Table on Market opportunity by Product ($ billion)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ billion)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: AbbVie Inc. – Overview
Exhibits120: AbbVie Inc. – Product / Service
Exhibits121: AbbVie Inc. – Key news
Exhibits122: AbbVie Inc. – Key offerings
Exhibits123: Aenova Holding GmbH – Overview
Exhibits124: Aenova Holding GmbH – Product / Service
Exhibits125: Aenova Holding GmbH – Key offerings
Exhibits126: Boehringer Ingelheim International GmbH – Overview
Exhibits127: Boehringer Ingelheim International GmbH – Business segments
Exhibits128: Boehringer Ingelheim International GmbH – Key news
Exhibits129: Boehringer Ingelheim International GmbH – Key offerings
Exhibits130: Boehringer Ingelheim International GmbH – Segment focus
Exhibits131: Catalent Inc. – Overview
Exhibits132: Catalent Inc. – Business segments
Exhibits133: Catalent Inc. – Key news
Exhibits134: Catalent Inc. – Key offerings
Exhibits135: Catalent Inc. – Segment focus
Exhibits136: Corden Pharma International GmbH – Overview
Exhibits137: Corden Pharma International GmbH – Product / Service
Exhibits138: Corden Pharma International GmbH – Key offerings
Exhibits139: Jubilant Pharmova Ltd. – Overview
Exhibits140: Jubilant Pharmova Ltd. – Business segments
Exhibits141: Jubilant Pharmova Ltd. – Key news
Exhibits142: Jubilant Pharmova Ltd. – Key offerings
Exhibits143: Jubilant Pharmova Ltd. – Segment focus
Exhibits144: Lonza Group Ltd. – Overview
Exhibits145: Lonza Group Ltd. – Business segments
Exhibits146: Lonza Group Ltd. – Key news
Exhibits147: Lonza Group Ltd. – Key offerings
Exhibits148: Lonza Group Ltd. – Segment focus
Exhibits149: Merck KGaA – Overview
Exhibits150: Merck KGaA – Business segments
Exhibits151: Merck KGaA – Key news
Exhibits152: Merck KGaA – Key offerings
Exhibits153: Merck KGaA – Segment focus
Exhibits154: NextPharma GmbH – Overview
Exhibits155: NextPharma GmbH – Product / Service
Exhibits156: NextPharma GmbH – Key offerings
Exhibits157: PerkinElmer Inc. – Overview
Exhibits158: PerkinElmer Inc. – Business segments
Exhibits159: PerkinElmer Inc. – Key news
Exhibits160: PerkinElmer Inc. – Key offerings
Exhibits161: PerkinElmer Inc. – Segment focus
Exhibits162: Piramal Enterprises Ltd. – Overview
Exhibits163: Piramal Enterprises Ltd. – Business segments
Exhibits164: Piramal Enterprises Ltd. – Key offerings
Exhibits165: Piramal Enterprises Ltd. – Segment focus
Exhibits166: Pyramid Laboratories Inc. – Overview
Exhibits167: Pyramid Laboratories Inc. – Product / Service
Exhibits168: Pyramid Laboratories Inc. – Key offerings
Exhibits169: Recipharm AB – Overview
Exhibits170: Recipharm AB – Business segments
Exhibits171: Recipharm AB – Key offerings
Exhibits172: Recipharm AB – Segment focus
Exhibits173: Siegfried Holding AG – Overview
Exhibits174: Siegfried Holding AG – Business segments
Exhibits175: Siegfried Holding AG – Key offerings
Exhibits176: Siegfried Holding AG – Segment focus
Exhibits177: Thermo Fisher Scientific Inc. – Overview
Exhibits178: Thermo Fisher Scientific Inc. – Business segments
Exhibits179: Thermo Fisher Scientific Inc. – Key news
Exhibits180: Thermo Fisher Scientific Inc. – Key offerings
Exhibits181: Thermo Fisher Scientific Inc. – Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Validation techniques employed for market sizing
Exhibits187: Information sources
Exhibits188: List of abbreviations